| abstract |
Heteroaryl compounds, such as compounds of formula I or IA, and pharmaceutical compositions thereof are provided herein. Also for the treatment, alleviation, or prevention of one or more symptoms of a disorder, disease, or condition mediated by casein kinase 1 (CK1), interleukin-1 receptor-related kinase (IRAK1), or cyclin-dependent kinase 9 (CDK9). Its usage is provided here. Expression: (I), (IA) |